Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
The following are the M&A deals, rumors and chatter circulating on Wall Street from Wednesday, November 2, 2016.
Broadcom Limited to Acquire Brocade Communications Systems for $12.75/Share
The Deal:
Broadcom Limited (NASDAQ: AVGO) and Brocade Communications Systems, Inc. (NASDAQ: BRCD) announced they have agreed that Broadcom will acquire Brocade for $12.75 per share in cash, or approximately $5.5 billion, plus $0.4 billion of net debt. The transaction, which is presently expected to close in H2 of Broadcom's FY 2017. Brocade closed at $12.32 on Wednesday, up 9.61 percent.
Rumor of Multiple Bidders for Angie's List
The Rumor:
Shares of Angie's List (NASDAQ: ANGI) spiked to a high of $8.13 Tuesday, on unconfirmed market chatter that there are multiple bidders for the consumer review website. An MKM Analyst said on Tuesday that "Angie's List could be an attractive asset for a strategic investor/ acquirer from a tangential space," while an Oppenheimer analyst stated that management is "likely focused on a strategic investment to accelerate growth vs. a potential sale."
Bary Diller’s IAC/InterActiveCorp offered $8.75 per share last November. A company spokesperson declined comment to Benzinga on potential current interest. Angie's List closed at $7.59 on Tuesday.
Valeant is Exploring Sale of Eye-Surgery Equipment Unit, Could Be Valued at $2.5B
The Rumor:
Valeant Pharmaceuticals (NYSE: VRX) is said to be exploring a sale of its eye-surgery equipment business for as much as $2.5 billion, according to sources as reported by the Wall Street Journal on Wednesday. Valeant acquired the business with its purchase of Bausch & Lomb. This follows a report on Tuesday that Valeant is in talks to sell its Salix Pharmaceuticals Ltd. stomach-drug business to Takeda Pharmaceutical Co. (OTC: TKPYY) for $10 billion.
Valeant closed Tuesday at $21.12, down 11.48 percent.
Inteliquent to be Acquired by GTCR for $23.00/Share
The Deal:
Inteliquent, Inc. (NASDAQ: IQNT) announced it has entered into a definitive agreement to be acquired by an affiliate of GTCR LLC and merged with a subsidiary of Onvoy, LLC for $23.00 per share in cash, for a total value of approximately $800 million. The transaction is expected to close in H1 of 2017. Inteliquent closed Tuesday at $16.74, and traded as high as $22.47 after-hours.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!